Translational Research in Ovarian Cancer

被引：2

作者：

Di Renzo, Maria Flavia ^{[1
,2
]}

Valabrega, Giorgio ^{[1
,2
]}

机构：

[1] Univ Torino, Dept Oncol, I-10124 Turin, Italy

[2] FPO IRCCS, Candiolo Canc Inst, I-10060 Candiolo, TO, Italy

来源：

CANCERS | 2020年 / 12卷 / 12期

关键词：

THERAPY;

D O I：

10.3390/cancers12123676

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 6 条

[1] Bevacizumab (Avastin®) in cancer treatment: A review of 15 years of clinical experience and future outlook [J].

Garcia, Josep ;

Hurwitz, Herbert, I ;

Sandler, Alan B. ;

Miles, David ;

Coleman, Robert L. ;

Deurloo, Regula ;

Chinot, Olivier L. .

CANCER TREATMENT REVIEWS, 2020, 86

[2] Ovarian Cancer Immunotherapy: Turning up the Heat [J].

Ghisoni, Eleonora ;

Imbimbo, Martina ;

Zimmermann, Stefan ;

Valabrega, Giorgio .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12)

[3] Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors [J].

McGee, J. ;

Bookman, M. ;

Harter, P. ;

Marth, C. ;

McNeish, I. ;

Moore, K. N. ;

Poveda, A. ;

Hilpert, F. ;

Hasegawa, K. ;

Bacon, M. ;

Gatsonis, C. ;

Brand, A. ;

Kridelka, F. ;

Berek, J. ;

Ottevanger, N. ;

Levy, T. ;

Silverberg, S. ;

Kim, B. -G. ;

Hirte, H. ;

Okamoto, A. ;

Stuart, G. ;

Ochiai, K. .

ANNALS OF ONCOLOGY, 2017, 28 (04) :702-710

[4] Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer [J].

McPherson, Andrew ;

Roth, Andrew ;

Laks, Emma ;

Masud, Tehmina ;

Bashashati, Ali ;

Zhang, Allen W. ;

Ha, Gavin ;

Biele, Justina ;

Yap, Damian ;

Wan, Adrian ;

Prentice, Leah M. ;

Khattra, Jaswinder ;

Smith, Maia A. ;

Nielsen, Cydney B. ;

Mullaly, Sarah C. ;

Kalloger, Steve ;

Karnezis, Anthony ;

Shumansky, Karey ;

Siu, Celia ;

Rosner, Jamie ;

Chan, Hector Li ;

Ho, Julie ;

Melnyk, Nataliya ;

Senz, Janine ;

Yang, Winnie ;

Moore, Richard ;

Mungall, Andrew J. ;

Marra, Marco A. ;

Bouchard-Cote, Alexandre ;

Gilks, C. Blake ;

Huntsman, David G. ;

McAlpine, Jessica N. ;

Aparicio, Samuel ;

Shah, Sohrab P. .

NATURE GENETICS, 2016, 48 (07) :758-+

[5] The forefront of ovarian cancer therapy: update on PARP inhibitors [J].

Mirza, M. R. ;

Coleman, R. L. ;

Gonzalez-Martin, A. ;

Moore, K. N. ;

Colombo, N. ;

Ray-Coquard, I ;

Pignata, S. .

ANNALS OF ONCOLOGY, 2020, 31 (09) :1148-1159

[6] PARP Inhibitors in the Management of Ovarian Cancer: ASCO Guideline [J].

Tew, William P. ;

Lacchetti, Christina ;

Ellis, Annie ;

Maxian, Kathleen ;

Banerjee, Susana ;

Bookman, Michael ;

Jones, Monica Brown ;

Lee, Jung-Min ;

Lheureux, Stephanie ;

Liu, Joyce F. ;

Moore, Kathleen N. ;

Muller, Carolyn ;

Rodriguez, Patricia ;

Walsh, Christine ;

Westin, Shannon N. ;

Kohn, Elise C. .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (30) :3468-+

← 1 →